Monkeypox: Things we know as of now

Published On 2022-07-30 03:30 GMT   |   Update On 2022-07-30 03:30 GMT
Advertisement

Outbreaks in the West along with periodic re-emergence of the disease in parts of Africa have generated concern among global health bodies due to the existent deficiency of guidelines for the management of the disease. A recent review in the Journal of the Association of Physicians of India JAPI throws light on this outbreak known as Monkeypox.

Genetic variations and altered mechanisms favoring better survival of the virus have made early identification of the disease during screening difficult, particularly in resource-limited settings like rural areas of Africa.

Advertisement

Through evidence gathered from experimental studies conducted after these outbreaks, the virus is known to be transmitted from several animal reservoirs along with human-to-human contact of blood, body fluids, or aerosol. Early diagnosis through immunoassays and polymerase chain reaction (PCR) tests, although not very specific, allows early treatment and subsequently better patient survival and recovery.

The presence of lymphadenopathy along with fever, sore throat, and a vesiculopustular rash is diagnostic. The virus affects the gastrointestinal, hematological, ocular, and respiratory systems, in a like manner producing afflictions of the specific system.

Treatment, through experimental data, has been preferred to be symptomatic, with the aim to prevent superinfections. Antivirals have been studied and used in clinical trials with favorable outcomes. Antiviral immunoglobulins have also been used with success in certain patients for post-exposure prophylaxis.

The periodic occurrence and frequency of such outbreaks bring to light the need for epidemic awareness, research, and preparedness. Although the availability of literature is limited, we must improvise upon research pertaining to the outcomes of conventional practices so as to devise specific, disease-modulating strategies to prevent transition to complications.

Reference: Deshmukh P, Vora A, Tiwaskar M, et al. Monkeypox: What do we know so far? A short narrative review of the literature. J Assoc Physicians India 2022;70(7):87–90.

Full View
Tags:    
Article Source : Journal of the Association of Physicians of India

Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.

NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News